Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 18 studies | 42% ± 20% | |
peripheral blood | 10 studies | 23% ± 7% | |
lung | 9 studies | 25% ± 6% | |
eye | 7 studies | 36% ± 11% | |
uterus | 5 studies | 30% ± 6% | |
pancreas | 4 studies | 33% ± 12% | |
breast | 4 studies | 25% ± 7% | |
intestine | 3 studies | 25% ± 7% | |
prostate | 3 studies | 28% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 24152.62 | 2638 / 2642 | 100% | 423.04 | 705 / 705 |
prostate | 99% | 9044.82 | 243 / 245 | 99% | 150.70 | 499 / 502 |
thymus | 99% | 6057.83 | 647 / 653 | 99% | 257.51 | 597 / 605 |
esophagus | 98% | 8662.70 | 1421 / 1445 | 98% | 276.78 | 179 / 183 |
skin | 100% | 9246.60 | 1803 / 1809 | 96% | 310.05 | 452 / 472 |
lung | 99% | 7205.57 | 571 / 578 | 96% | 217.34 | 1105 / 1155 |
ovary | 100% | 10497.16 | 180 / 180 | 93% | 119.52 | 399 / 430 |
uterus | 100% | 11486.86 | 170 / 170 | 91% | 195.49 | 419 / 459 |
bladder | 100% | 11592.71 | 21 / 21 | 86% | 194.34 | 432 / 504 |
breast | 98% | 7095.69 | 449 / 459 | 87% | 115.48 | 975 / 1118 |
adrenal gland | 92% | 4264.38 | 238 / 258 | 89% | 236.73 | 205 / 230 |
kidney | 79% | 3358.45 | 70 / 89 | 95% | 141.44 | 856 / 901 |
intestine | 90% | 13878.61 | 873 / 966 | 79% | 79.44 | 418 / 527 |
stomach | 62% | 5910.35 | 224 / 359 | 83% | 96.56 | 238 / 286 |
pancreas | 17% | 499.58 | 55 / 328 | 94% | 137.62 | 167 / 178 |
liver | 51% | 2164.42 | 115 / 226 | 50% | 42.24 | 203 / 406 |
tonsil | 0% | 0 | 0 / 0 | 100% | 244.18 | 45 / 45 |
blood vessel | 100% | 10397.17 | 1330 / 1335 | 0% | 0 | 0 / 0 |
adipose | 99% | 6498.24 | 1193 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 76.14 | 27 / 29 |
heart | 91% | 7633.21 | 780 / 861 | 0% | 0 | 0 / 0 |
spleen | 90% | 3687.02 | 217 / 241 | 0% | 0 | 0 / 0 |
muscle | 83% | 4029.60 | 664 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 76% | 75.83 | 61 / 80 |
peripheral blood | 13% | 387.16 | 118 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051260 | Biological process | protein homooligomerization |
GO_0070885 | Biological process | negative regulation of calcineurin-NFAT signaling cascade |
GO_1904645 | Biological process | response to amyloid-beta |
GO_0046686 | Biological process | response to cadmium ion |
GO_0050730 | Biological process | regulation of peptidyl-tyrosine phosphorylation |
GO_0001933 | Biological process | negative regulation of protein phosphorylation |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0032689 | Biological process | negative regulation of type II interferon production |
GO_1900272 | Biological process | negative regulation of long-term synaptic potentiation |
GO_0006979 | Biological process | response to oxidative stress |
GO_0051726 | Biological process | regulation of cell cycle |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0010955 | Biological process | negative regulation of protein processing |
GO_1901379 | Biological process | regulation of potassium ion transmembrane transport |
GO_0090314 | Biological process | positive regulation of protein targeting to membrane |
GO_0097062 | Biological process | dendritic spine maintenance |
GO_1902951 | Biological process | negative regulation of dendritic spine maintenance |
GO_0032700 | Biological process | negative regulation of interleukin-17 production |
GO_0006878 | Biological process | intracellular copper ion homeostasis |
GO_1900449 | Biological process | regulation of glutamate receptor signaling pathway |
GO_0032703 | Biological process | negative regulation of interleukin-2 production |
GO_1902430 | Biological process | negative regulation of amyloid-beta formation |
GO_0031648 | Biological process | protein destabilization |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_1902992 | Biological process | negative regulation of amyloid precursor protein catabolic process |
GO_1904646 | Biological process | cellular response to amyloid-beta |
GO_0050850 | Biological process | positive regulation of calcium-mediated signaling |
GO_0007611 | Biological process | learning or memory |
GO_1905664 | Biological process | regulation of calcium ion import across plasma membrane |
GO_0050860 | Biological process | negative regulation of T cell receptor signaling pathway |
GO_0007616 | Biological process | long-term memory |
GO_1990535 | Biological process | neuron projection maintenance |
GO_0043525 | Biological process | positive regulation of neuron apoptotic process |
GO_1903078 | Biological process | positive regulation of protein localization to plasma membrane |
GO_0071280 | Biological process | cellular response to copper ion |
GO_0050731 | Biological process | positive regulation of peptidyl-tyrosine phosphorylation |
GO_0046007 | Biological process | negative regulation of activated T cell proliferation |
GO_1900451 | Biological process | positive regulation of glutamate receptor signaling pathway |
GO_0045121 | Cellular component | membrane raft |
GO_0043195 | Cellular component | terminal bouton |
GO_0098794 | Cellular component | postsynapse |
GO_0009986 | Cellular component | cell surface |
GO_0070062 | Cellular component | extracellular exosome |
GO_0019898 | Cellular component | extrinsic component of membrane |
GO_0030425 | Cellular component | dendrite |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0009897 | Cellular component | external side of plasma membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016234 | Cellular component | inclusion body |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005829 | Cellular component | cytosol |
GO_0031965 | Cellular component | nuclear membrane |
GO_0140677 | Molecular function | molecular function activator activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0043008 | Molecular function | ATP-dependent protein binding |
GO_0140693 | Molecular function | molecular condensate scaffold activity |
GO_0038023 | Molecular function | signaling receptor activity |
GO_1903135 | Molecular function | cupric ion binding |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0001540 | Molecular function | amyloid-beta binding |
GO_0031805 | Molecular function | type 8 metabotropic glutamate receptor binding |
GO_0002020 | Molecular function | protease binding |
GO_0051087 | Molecular function | protein-folding chaperone binding |
GO_0005539 | Molecular function | glycosaminoglycan binding |
GO_0044325 | Molecular function | transmembrane transporter binding |
GO_0005507 | Molecular function | copper ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0031802 | Molecular function | type 5 metabotropic glutamate receptor binding |
GO_0015631 | Molecular function | tubulin binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0019828 | Molecular function | aspartic-type endopeptidase inhibitor activity |
GO_0005521 | Molecular function | lamin binding |
GO_0008017 | Molecular function | microtubule binding |
GO_1903136 | Molecular function | cuprous ion binding |
Gene name | PRNP |
Protein name | Alternative prion protein Prion protein PrP amyloid Alternative prion protein (AltPrP) Major prion protein Major prion protein (PrP) (ASCR) (PrP27-30) (PrP33-35C) (CD antigen CD230) |
Synonyms | hCG_1785425 ALTPRP PRP PRIP |
Description | FUNCTION: Its primary physiological function is unclear. May play a role in neuronal development and synaptic plasticity. May be required for neuronal myelin sheath maintenance. May promote myelin homeostasis through acting as an agonist for ADGRG6 receptor. May play a role in iron uptake and iron homeostasis. Soluble oligomers are toxic to cultured neuroblastoma cells and induce apoptosis (in vitro) (By similarity). Association with GPC1 (via its heparan sulfate chains) targets PRNP to lipid rafts. Also provides Cu(2+) or Zn(2+) for the ascorbate-mediated GPC1 deaminase degradation of its heparan sulfate side chains (By similarity). . |
Accessions | K0P2W7 Q53YK7 X6RKS3 A0A6J4EE43 B2NI05 Q7KYY8 Q540C4 D4P3Q7 ENST00000457586 Q86XR1 P04156 Q6FGN5 ENST00000457586.2 [P04156-1] B2NI04 Q6FGR8 O75942 A1YVW6 Q16409 Q6SES1 A2A2V1 F7VJQ1 ENST00000379440.9 [P04156-1] ENST00000424424.2 [P04156-1] ENST00000430350.2 [P04156-1] ENST00000424424 |